Dr. Reddy’s Laboratories has informed that the Company has received an order dated November 12, 2024, from COFEPRIS (Comisión Federal para la Protección Contra Riesgos Sanitarios) health department of Mexico. The details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III Para A Sub Para 20 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed.
The above information is a part of company’s filings submitted to BSE.
